Drug
Neramexane clinical trials
Includes 7 studies of Neramexane mesylate.
- studies test it
- 16
- open now
- 0
- in phase 3
- 5
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
Studies by the year they started
16 studies that test it; most in 2009 (9)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 4 |
| 2009 | 9 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 3
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 16 · Other 0
Studies
Open first, then newest update. How each study uses neramexane is read from its arms, and is right about nine times in ten.
Testing it · 16
- Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective TinnitusCompletedPhase 3Merz Pharmaceuticals GmbHNCT00739635Written as Neramexane mesylate
- Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective TinnitusCompletedPhase 3Merz Pharmaceuticals GmbHNCT00955799Written as Neramexane mesylate
- Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective TinnitusTerminatedPhase 3Merz Pharmaceuticals GmbHNCT00827008Written as Neramexane mesylate
- The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's DiseaseCompletedPhase 3Forest LaboratoriesNCT00090116Written as Neramexane
- Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female SubjectsCompletedPhase 1Merz Pharmaceuticals GmbHNCT00915174Written as Neramexane
- Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese SubjectsCompletedPhase 1Merz Pharmaceuticals GmbHNCT00983099Written as Neramexane
- Neramexane for TinnitusCompletedPhase 2Merz Pharmaceuticals GmbHNCT00405886Written as Neramexane
- Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult SubjectsCompletedPhase 1Merz Pharmaceuticals GmbHNCT00978614Written as Neramexane
- Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane MesylateCompletedPhase 1Merz Pharmaceuticals GmbHNCT00955760Written as Neramexane
- A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male SubjectsCompletedPhase 1Merz Pharmaceuticals GmbHNCT01109680Written as Neramexane
- Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of NeramexaneCompletedPhase 1Merz Pharmaceuticals GmbHNCT00936026Written as Neramexane
- Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification RegimenCompletedPhase 1Merz Pharmaceuticals GmbHNCT00972127Written as Neramexane
- Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective TinnitusCompletedPhase 3Merz Pharmaceuticals GmbHNCT00772980Written as Neramexane mesylate
- Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired NystagmusTerminatedPhase 2Merz Pharmaceuticals GmbHNCT00799942Written as Neramexane mesylate
- Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy VolunteersCompletedPhase 1Merz Pharmaceuticals GmbHNCT00712283Written as Neramexane mesylate
- Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired NystagmusCompletedPhase 2Merz Pharmaceuticals GmbHNCT00661440Written as Neramexane mesylate
Codes
What other systems call neramexane · ClinicalTrials.gg INT004093
- MeSH (NLM) C114144neramexaneOne source NLM
- UNII (FDA) 856DX0KJ84NERAMEXANEConfirmed FDA, NLM, Wikidata
- Wikidata Q6995889neramexaneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76781NeramexaneOne source FDA
- DrugBank DB04926One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C114144 | neramexane | One source NLM |
| UNII (FDA) | 856DX0KJ84 | NERAMEXANE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6995889 | neramexane | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76781 | Neramexane | One source FDA |
| DrugBank | DB04926 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.